Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants

Annals of Clinical and Laboratory Science

Volumn 40, Issue 4, 2010, Pages 330-335

  Kim, Yonggoo ^a   Yang, Chul Woo ^a   Moon, In Sung ^a   Kim, Myungshin ^a   Lim, Jihyang ^a   Park, Yeon Joon ^a   Han, Kyungja ^a   Oh, Eun Jee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Acute antibody mediated rejection; Donor specific HLA antibodies; Renal transplantation

Indexed keywords

ANTIBODY; CREG ANTIBODY; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE ANTIGEN PANEL REACTIVE ANTIBODY TEST;

ADULT; ANTIBODIES; ANTIBODY SPECIFICITY; COMPLEMENT SYSTEM PROTEINS; CROSS REACTIONS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77958050695     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Worthington JE, Thomas AA, Dyer PA, Martin S. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome. Transplantation 1998;65:121-125.
2. Schönemann C, Groth J, Leverenz S, May G. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance. Transplantation 1998;65:1519-1523.
3. Süsal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002;73:1269-1273.
4. Magee CC. Transplantation across previously incompatible immunological barriers. Transpl Int 2006;19:87-97.
5. Rodey GE, Neylan JF, Whelchel JD, Revels KW, Bray RA. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994;39:272-280.
6. Piazza A, Poggi E, Ozzella G Borrelli L, Monaco PI, Scornajenghi A, Tisone G, Adorno D. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flowcytometric techniques. Transplantation 2006;81: 1298-1305.
7. Barocci S, Valente U, Nocera A. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Clin Transplant 2007;21:47-56. (Pubitemid 46189587)
8. Cha CH, Oh HB, Kim MH, Chae JM, Jung SY. Development of a web-based program for the identification of human leukocyte antigen antibody specificities Korean J Lab Med 2007;27:458-463.
9. Egfjord M, Jakobsen BK, Ladefoged J. No impact of cross-reactive group human leucocyte antigen class I matching on long-term kidney graft survival. Scand J Immunol 2003;57:362-365. (Pubitemid 36408207)
10. Laux G, Opelz G. Immunological relevance of CREG matching in cadaver kidney transplantation. Transplantation 2004;78:442-446. (Pubitemid 39095412)
11. Zachary AA, Leffell MS. Detecting and monitoring human leukocyte antigen-specific antibodies. Hum Immunol 2008;69:591-604.
12. Magee B, Martin J, Middleton D. The repercussions of implementing flowcytometry as a single HLA antibody screening technique in prospective renal transplant recipients. Transpl Int 2006;19:105-109.
13. El-Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005;66:989-997. (Pubitemid 41790535)
14. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003;75:43-49. (Pubitemid 36139693)
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
16. Yang CW, Oh EJ, Lee SB, Moon IS, Kim DG, Choi BS, Park SC, Choi YJ, Park YJ, Han K. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Transplant Proc 2006;38:2803-2806.
17. Parham P, Adams EJ, Arnett KL. The origins of HLAA, B,C polymorphism. Immunol Rev 1995;143:141-180.
18. Laundy GJ, Bradley BA. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation. Transplantation 1995;59:1207-1213.
19. Gebel HM, Bray RA, Nickerson P. Pretransplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003;3:1488-1500.
20. Schaub S, Scornik JC. High-tech detection of HLA antibodies and complement: prospects and limitations. Am J Transplant 2008;8:5-6.
21. El-Awar N, Lee JH, Tarsitani C, Terasaki PI. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Hum Immunol 2007;68:170-180. (Pubitemid 46356650)
22. Cornell LD, Smith RN, Colvin RB. Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol 2008;3:189-220. (Pubitemid 351488280)
23. Zhang Q, Liang LW, Gjertson DW, Lassman C, Wilkinson AH, Kendrick E, Pham PT, Danovitch GM, Gritsch HA, Reed EF. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 2005;79:591-598.
24. Cecka JM. The role of HLA in renal transplantation. Hum Immunol 1997;56:6-16.
25. Li X, Ishida H, Yamaguchi Y, Tanabe K. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Transpl Int 2008;21:1145-1152.
26. Tait BD. Solid phase assays for HLA antibody detection in clinical transplantation. Curr Opin Immunol 2009; 21:573-577.